Replies to post #165677 on Biotech Values

[vinmantoo]

Poorgradstudent, I am more surprised that Bayer didn't buy ONXX.

[jq1234]

AMGN offered $120 based on public info, so apparently they were comfortable with risk at that price range. Final price isn't much different from original offer. If there were other bidders, valuation got higher, a CVR would be more likely.